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Background: Epidemiological transition (ET) theory, first postulated in 1971, has developed alongside changes
in population structures over time. However, understandings of mortality transitions and associated epide-
miological changes remain poorly defined for public health practitioners. Here, we review the concept
and development of ET theory, contextualising this in empirical evidence, which variously supports and
contradicts the original theoretical propositions.
Design: A Medline literature search covering publications over four decades, from 1971 to 2013, was conducted.
Studies were included if they assessed human populations, were original articles, focused on mortality and
health or demographic or ET and were in English. The reference lists of the selected articles were checked for
additional sources.
Results: We found that there were changes in emphasis in the research field over the four decades. There was
an increasing tendency to study wide-ranging aspects of the determinants of mortality, including risk factors,
lifestyle changes, socio-economics, and macro factors such as climate change. Research on ET has focused
increasingly on low- and middle-income countries rather than industrialised countries, despite its origins in
industrialised countries. Countries have experienced different levels of progress in ET in terms of time, pace,
and underlying mechanisms. Elements of ET are described for many countries, but observed transitions have
not always followed pathways described in the original theory.
Conclusions: The classic ET theory largely neglected the critical role of social determinants, being largely a
theoretical generalisation of mortality experience in some countries. This review shows increasing interest in ET
all over the world but only partial concordance between established theory and empirical evidence. Empirical
evidence suggests that some unconsidered aspects of social determinants contributed to deviations from classic
theoretical pathways. A better-constructed, revised ET theory, with a stronger basis in evidence, is needed.
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C
hanges in mortality patterns and increases in
life expectancy, with subsequent impacts on pop-
ulation, have been documented in industrialised
countries since the 19th century. Early studies on popula-
tion change over time were overviewed from a demographic
rather than epidemiological perspective (1), including
Thompson’s early work observing changes in fertility
and mortality rates in populations (2). Landry introduced
the term ‘demographic transition’ in describing secular
changes in fertility and mortality in 1934, later reprinted in
English (3). This idea was further developed in association
with socio-economic development (4). In 1971, Omran
proposed a theory of ‘epidemiological transition (ET)’,
which grew out of the demographic transition model and
incorporated more detailed consideration of particular
diseases as causes of death. He particularly based this on
mortality changes in England, Wales, Japan, and Sweden
during the 19th century (5).
Global Health Action
Global Health Action 2014.# 2014 Ailiana Santosa et al. This is an Open Access article distributed under the terms of the Creative Commons CC-BY 4.0
License (http://creativecommons.org/licenses/by/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix,
transform, and build upon the material for any purpose, even commercially, provided the original work is properly cited and states its license.
1
Citation: Glob Health Action 2014, 7: 23574 - http://dx.doi.org/10.3402/gha.v7.23574
(page number not for citation purpose)
This ET theory, in five propositions, describes changing
population patterns in terms of fertility, life expectancy,
mortality, and leading causes of death (5). The first pro-
position states that mortality is an important aspect of
population dynamics. The second proposition describes
changes in disease and mortality patterns, as ‘pandemics
of infectious disease are gradually shifted by degenerative
and man-made diseases as the leading cause of morbidity
and main cause of death’. The third proposition explains
that children and young women experience the most
profound impacts of ET, resulting in declining infant
and maternal mortality and reduced fertility rates. The
fourth proposition links long-term population changes in
health and disease patterns to demographic, economic,
and social determinants and mortality changes. The final
proposition outlines three basic variants of ET that
are functions of ‘peculiar variations in the pattern, the
pace, the determinants and the consequences of popula-
tion change’.
Omran proposed three stages of transition as under-
lying the changes in patterns of mortality and morbidity.
The first stage, ‘the age of pestilence and famine’, is
characterised by high and fluctuating mortality due to
epidemics, famines and war, and poor living conditions. In
this stage, a combination of high crude death rate, high
fertility rate, and low life expectancy at birth (between 20
and 40 years) results in slow population growth. The most
common causes of death are infectious and parasitic
diseases, especially among children and women of child-
bearing age. The second stage, ‘the age of receding
pandemics’, witnesses declining mortality rates, initially
high but later decreasing fertility, and life expectancy at
birth increasing to around 55 years. The major driving
forces in this stage of transition are sanitation improve-
ments, control of major outbreaks of infectious diseases,
and medical breakthroughs (including contraception).
While infectious diseases remain as major causes of
death, non-communicable diseases (NCDs) start to in-
crease steadily. The third stage, ‘the age of degenerative
and man-made disease’, is characterised by decreasing and
relatively stable low mortality and increasing life expec-
tancy at birth to over 70 years, manifesting in a population
that is ageing. In this stage, NCDs dominate causes of
death, with many deaths attributable to cardiac and
cerebrovascular ailments, chronic lung and metabolic
diseases, cancers, injuries, and stress-related disorders (5).
In 1983, Omran recognised the need to update his
theory to incorporate a more extended description of the
transition, as emerging analyses of transition patterns
based on historical data did not fit the original model
(6). Omran later acknowledged the presence of one and
possibly two additional stages to his original theory of
ET. He added the fourth stage as ‘the age of declin-
ing cerebrovascular mortality, ageing, lifestyle modifica-
tions and resurgent diseases’, during which life expectancy
continues to increase (up to 8085 years), and the mor-
tality attributed to cardiovascular diseases declines and
stabilises as a result of improved medical care and
lifestyle modifications. Omran’s fifth stage was charac-
terised by the emergence of new diseases (HIV/AIDS,
hepatitis) and re-emergence of old diseases (cholera, malaria,
diphtheria, tuberculosis, plague) (7), which were already
being described by others (8, 9). In his original fifth pro-
position, Omran proposed three basic variants of transi-
tion, but later added an additional model, similar to the
classic model but starting several decades later and passing
faster through the different stages of the transition (7).
Critiques on Omran
The applicability and universality of ET theory across
various places and contexts remain contentious (1022).
Criticisms of ET theory as over-simplistic peaked in the
1990s on the basis that it failed to understand the com-
prehensive nature and historical sequence of mortality
transitions (10, 1417, 22). A major critique of Omran’s
theory is the assumption that all countries will experience
similar linear progression of transitions with respect to
onset and speed. However, not all countries necessarily
encounter ET in the same way. Omran treated entire
populations as undifferentiated units; his conclusions
drawn from the mortality statistics of Sweden, England,
and Wales have been considered contestable; that the
theory ‘fails to grasp the global nature and the historical
sequence of the mortality transition as it spread’, and that
it is ‘insufficiently epidemiological in that its focus was
the changing causes of death rather than the changing
causes of patterns of illness’ (23). Mackenbach argued that
the ET theory is ambiguous because it was developed
based on Western data and it is difficult to ascertain the
beginning and end of the transition (20). In addition,
Frenk et al. (18) and Smallman-Raynor and Phillips (19)
challenged the assumptions of ET theory’s unidirectional
structure and continuous development, introducing the
concepts of counter transition and epidemiological polar-
isation. It was also suggested that ET was part of a
broader effort to reorient American and international
health institutions towards the pervasive population con-
trol agenda of the 1960s and 1970s rather than focusing on
the increasing burden of chronic disease (13).
The generalisability of ET theory has been doubted,
based on the great variations in mortality trends among
population subgroups (14, 21). Ruzicka and Kane exam-
ined inequalities in mortality and concluded that mortal-
ity patterns vary widely by race, sex, economic indicators,
and class, resulting in substantial ‘heterogeneity within
social class and within any other socio-cultural, demo-
graphic or economic category’. They criticised the ET
theory for the assumption that communities will gradually
progress to the point where they have virtually elimi-
nated infectious diseases as a major health threat (15).
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Gaylin and Kates determined the importance of morbid-
ity and mortality differences between population sub-
groups, using the HIV/AIDS pandemic as a case study,
and showed important inconsistencies with the optimistic,
equitable trends implied by ET theory, suggesting that the
modern picture may be more complex than the original
theory could predict (21).
Carolina and Gustavo examined the validity of ET
theory as an effective model in the interpretation of mor-
tality and morbidity changes, with reference to Mexico
and to low- and middle-income countries (LMICs) in
general. They found that the main theoretical problem
in using the ET theory related to a preference for
phenomenological descriptions rather than theoretical
explanations of the causal patterns of death and disease
and their links with the changes experienced in societies.
Interpretations using the ET theory were inevitably based
on scientific and social perspectives frozen at the time of
its use (17). The paradox was that researchers frequently
misunderstood ET theory as representing more or less
the same concept as Omran’s description of demographic
transition, casting it as a theory about changing disease
conditions progressing everywhere in a uniform and linear
manner. Despite his reliance on its main concepts, Omran
explicitly rejected demographic transition as a theoretical
framework, postulating that ET was formulated in an
attempt to provide a more comprehensive approach to the
dynamics of the mortalityfertility transition. In his view,
recent mortality declines in the developing world de-
pended not on economic development but on national
and international programs of health service provision
and environmental control. However, this viewpoint con-
trasted with the thesis of McKeown et al. that broad
population shifts in disease occurrence during transitions
to industrialised societies, from declines in infectious
disease to increases in NCDs, were due to improved nutri-
tion and increased exposure to ‘conditions for which we
are genetically ill-equipped’ (24). Preston pointed out that
mortality is not associated with economic growth and the
theory becomes weaker at very low levels of income (25).
In addressing the conceptual drawbacks of the theory,
the term ‘health transition’ was coined to incorporate
new elements into Omran’s theoretical assumptions
(10, 12). Health transition was described as ‘a dynamic
process whereby the health and disease patterns of a
society evolve in diverse ways as a response to broader
demographic, socio-economic, technological, political,
cultural and biological changes’, and divided into ET
(changes in health patterns) and health care transition
(the organised response to health conditions). Omran,
however, argued that the health transition is part of the
ET, not vice versa (6). The concept of ‘health transition’
was proposed as a wider framework that included not only
epidemiological characteristics but also the ways in which
societies responded to changing health situations as a
result of cultural, social, and behavioural determinants
(22, 23, 26, 27).
Clear understanding of mortality transition and its
implications is still hampered due to a lack of evidence
from LMICs (28). The lack of quality mortality data in
many parts of the world makes it difficult to understand
the generalisability of the theory globally, as well as
its interpretation. Changes in disease classifications over
time also limit the comparability of available data for
assembling a comprehensive pattern of mortality tran-
sition (29). The theory itself received relatively little
attention before the global incidence of NCDs increased
in the 1990s. An overview of how the ET theory has been
applied since its conception, and the identification of gaps
where it fails, are warranted.
Objectives
This paper intends to synthesise published evidence
on mortality transition, and, if possible, assess how ET
theory has been applied in understanding the transition
in specific contexts. More specifically, this paper aims
to answer the following questions: 1) What evidence on
mortality transition is available, who are the beneficiaries
during the transitions, and what are the socialeconomic
determinants that coexist with the ET?; 2) What exist-
ing evidence is available to illustrate changing patterns
of causes of death?; and 3) What deviations from the
classic ET theory have been observed, and do these reveal
emerging patterns?
Methods
We conducted a systematic review in PubMed using the
keywords ‘epidemiological transition (s) or epidemiologic
transition(s) or demographic transition(s) or health tran-
sition(s)’ and ‘mortality’. We selected these keywords to
cover a wide range of transitions, including health and
demographic transitions that are related to ET. We in-
cluded only articles on human research, and published in
English between 1 January 1971 and 31 December 2013.
We obtained 547 articles, which were later screened by
reading their titles and abstracts. From this step, a total
of 324 articles were excluded (210 irrelevant papers and
114 reviews/commentaries/editorials). Review papers in-
cluding Omran’s and Caldwell’s conceptual papers were
excluded but used to provide framework in the ‘Discus-
sion section’. The full texts of remaining 223 articles were
searched and read through. From this step, we obtained
16 additional articles, not found in the original search,
from the reference lists of relevant studies and review
articles. We could not obtain full text for 29 papers.
Therefore, only a total of 210 articles were included for
full text review in the second step. All citations were saved
in the PubMed database and imported into the EndNote
X6 database. All full-text articles were reviewed by two of
the authors for inclusion in the study. Uncertainties over
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study inclusion were discussed between the researchers
and resolved through consensus. Another 74 papers
were further excluded after reading the full text, mainly
because of insufficient mortality data (n23), observa-
tional studies assessing risk factors and outcomes in
a defined population (n17), and papers not directly
relevant to this study (n34). A final 136 articles were
included in the review. Details of this literature search are
summarised in Fig. 1.
Results
Of the 136 articles, 112 articles were performed in single
countries, and the other 24 articles were conducted in
multiple countries in which some of multi-countries stud-
ies used the Global Burden of Disease models. Seventy-
five out of the 136 articles (55%) used individual-level
data, and the remaining 45% used ecological data. Fifty
papers (37%) used historical data before Omran’s theory
was postulated in 1970, and the remaining 63% focused
more on contemporary society after 1970. Seventy-nine
of the articles (58%) reported time trends in outcome
indicators, while the remaining 42% reported cross-
sectional observations.
The main outcome indicator used in most studies was
mortality rate (either total, sex specific, age specific, and/
or cause specific), which was used in 117 articles (87%).
The remaining 13% articles used absolute number or
proportion of deaths (9%), DALY (3%), life expectancy
and standardised mortality ratio (1%). On disease out-
comes reported, 49% of the papers examined both all
and cause-specific deaths, 27% only focused on all-cause
deaths, and 24% reported cause-specific deaths.
With regard to the research questions, 50 papers (37%)
assessed trends in outcome indicators, with 37 additional
papers (27%) analysing both the trends and their deter-
minants. Twenty-three papers (17%) reported the preva-
lence of the outcome indicators, and 21 additional papers
(15%) reported both the prevalence and their determi-
nants. Five papers (4%) reported both the prevalence and
the trends of the outcome indicators. Twenty-nine papers
(21%) reported results from studies in rural areas, 1%
in urban areas, 16 papers (12%) in both urban and rural
areas, and 90 papers (66%) did not characterise the
study area. A total of 112 papers (82%) reported results
from studies in general populations, 16 papers (12%) on
children under 15 years, and eight papers (6%) on adults
aged 15 years and above (Table 1).
16 additional papers 
from reference list
Included (n=136)
Excluded (n= 103)
No full text (n=29)
Insufficient mortality data (n=23)
Only risk factors and outcomes (n=17)
Not directly relevant for this study (n=34)
Search and read for full-text 
(n=239)
Excluded (n=324) 
Irrelevant (n=210)
Review/editorial/ 
commentary (n=114)
Included (n= 223)
Articles screened on basis of title 
and abstract
Search results (n=547)
Article search in Pubmed
Keywords: epidemiological transition(s) or epidemiologic transition(s) or
demographic transition(s) or health transition(s) and mortality
Inclusion criteria: articles on human research, and published in English
between 1 January 1971 and 31 December 2013
Fig. 1. Flow diagram of the literature search process.
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Discussion
Omran’s theoretical concept of ET has broadly been
used in public health because it offers explanations for
changing cause-of-death patterns corresponding to dif-
ferent stages of transition. Most studies reviewed in this
paper described the theory in relation to specific situa-
tions in particular countries, rather than considering its
generalisability. Our review attempts to overview pub-
lished evidence over four decades on mortality transition
in relation to the ET theory. We structure the discussion
in several sections to discuss how the empirical research
articles illustrate the overall and cause-specific mortality
transitions, and whether deviation from the ET theory
and emerging patterns have been observed. A compre-
hensive exploration of health and ET in each country
included in this review, as well as a thorough review
of historical demographic research that led to Omran’s
theory, is beyond the scope of this paper.
What evidence on overall mortality transition exists?
Many studies have confirmed Omran’s first proposition
on ‘mortality as a fundamental factor in population
dynamics’. In many countries, mortality in the population
decreased significantly in the past century, alongside
decreasing fertility, increasing life expectancy, and a
growing number of older population. In this section, we
review papers, which discuss how transition of mortality
has occurred and how it influenced the population
structure over a period of time.
Mortality decline has been observed with different
speeds of transition in the population among all age
groups (17, 32, 34, 53, 55, 61, 65, 67, 75, 86, 91, 98, 106,
114, 116, 123, 124, 145) and across specific age groups,
including neonates and infants (50, 99, 117), children (35,
56), adolescents (142), and adults (73, 85, 127). In some
countries  such as Spain, Japan, Mexico, and Sri Lanka
 good quality vital registration allows researchers to
study mortality transition over long time periods. The
mortality rate in Spain increased during the 19th century
and peaked at the end of the century, after which the rate
decreased at a rate of 2.3 deaths per 1,000 population per
decade during the 20th century (114, 116). During the
20th century, many countries experienced quite similar
reductions in death rates with a reduction between 2 and
3 deaths per 1,000 population in a decade, such as in
Japan (91) and Mexico (17). These data illustrate how the
speed of mortality transition has become faster over time.
Decreasing fertility and birth rates led to an increase in
life expectancy and a change in the population structures
(35, 75, 114). While the mortality rate in Spain started
decreasing by the end of the 19th century, the birth
rate did not start declining until 1930. Since then, it has
decreased by two-thirds and reached the level of 9.75 per
1,000 population by the end of the 1980s. The proportion
of population dying at 70 years or older changed from
25% in the beginning of the 19th century to 74% by the
end of the 20th century (114). Chile experienced a faster
transition, with the proportion of deaths among older
people over 65 years doubling from 35 to 60% during a
22-year period (19701992) (75). In Monaco, the fertility
rate halved within a 30-year period (19802011), with
29% of the population being children under 15 years and
7% older people aged 65 (35).
In contrast to the general pattern of decreasing
mortality during the 20th century, populations in several
settings experienced stagnation of mortality reductions,
such as Eastern European countries (147), and even re-
versal of mortality, such as in Nauru (131), Philadelphia
in the USA (66), Russia (152), South Africa (3840),
Tanzania (46), and Thailand (101). A high rate of tuber-
culosis mortality among the adult population, which slowed
down the increase in life expectancy, was observed in
Philadelphia during the beginning of the 20th century (66).
In Nauru, the age-standardised mortality rate among adult
men doubled during 19601981, mainly due to the high
Table 1. Regions and countries from where the papers included in this review originated (n136 papers)
Papers
Africa Ethiopia (30, 31), Ghana (32), Malawi (33), Mauritius (34), Morocco (35), Seychelles (36, 37), South Africa (3844),
Sub-Saharan Africa (45), Tanzania (46)
America  North Canada (4752), Cuba (53, 54), Costa Rica (55), Haiti (56), Jamaica (57), Mexico (17, 5863), Trinidad and Tobago
(64, 65), USA (6668)
America  South Brazil (6974), Chile (75), Peru (76, 77), Colombia (78)
Asia China (7983), Hong Kong (84), India (25, 8589), Israel (90), Japan (91, 92), Korea (9395), Palestine (96),
Russian (97), Singapore (98), Sri Lanka (99), Thailand (100, 101), Turkey (102), Vietnam (103, 104)
Europe Bolivia (105), Bulgaria (106), Czech Republic (107), France (108), Hungary (109), Lithuania (110, 111), The
Netherlands (112, 113), Spain (114119), Sweden (120123), United Kingdom (124, 125)
Pacific Australia (126, 127), Fiji (128), French Polynesia (129, 130), Nauru (131, 132), New Zealand (133, 134)
Multi-countries WHO databases, mainly from World Health Statistics and Global Burden of Disease database (135150), national
data (151156), Human mortality database (157159), Demographic Health Surveillance System in INDEPTH
Network (160, 161), other databases (147, 162164)
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burden of chronic NCDs (131). In rural South Africa,
Kahn et al. demonstrated significant increases in mortality
for men and women, mainly due to the HIV epidemic,
during the last decade of the 20th century, with life
expectancy decreasing rapidly by 12 years in females and
14 years in males in a 10-year period (38). The overall
mortality rate increased by 87% from 1992 to 2005 (39).
In Thailand, the generalised HIV epidemic since the
1990s has led to an increase in male mortality rate and
a decreased life expectancy by 4 years during 1990
2000 (101).
Some studies have been conducted in indigenous
populations in Bolivia (105), Canada (50, 52), Mexico
(61), New Zealand (133), and Sweden (120, 121). Indigen-
ous populations tend to have higher birth rates, mortality
rates, and lower life expectancy than the general popula-
tion, as has been observed among sub-Arctic Indians in
Canada (50) and the aboriginal Maori population in
New Zealand (133). The Zapotec-speaking genetic isolate
in the Valley of Oaxaca, southern Mexico, experienced
mortality crises during 19301950 with the measles epi-
demic, resulting in deaths exceeding births. After 1955,
birth and death rates diverged in a pattern typical of rapid
population growth in early Stage II of the demographic
transition (61). Recent evidence has shown that health
among indigenous populations has improved over time, as
has been observed among the Sami population in Sweden
by the end of 19th century (120), and among the Tsimane
Amerindian population in Bolivia during the second half
of the 20th century (105). In Sweden, the gaps in infant
mortality rate (IMR) between the Sami and non-Sami
populations became narrower over time. Despite these
improvements, health inequality persisted between the
south Sami and the north Sami (121).
Evidence of transition among children and young women
In his third proposition, Omran stated that ‘During the
epidemiologic transition the most profound changes in
health and disease patterns obtain among children and
young women’. Evidence from many countries in this
review supports this claim (17, 32, 35, 53, 56, 58, 64, 66, 67,
72, 75, 80, 86, 95, 102, 107, 114, 116, 124, 128, 142, 146,
158). For example, the IMR and perinatal mortality rate
decreased steadily in Chile during 19701992, while the
neonatal mortality rate has been stable since the 1970s
(75). During 19922011, the mortality rate among children
in Morocco decreased by more than 40% over a 20-year
period (a decrease of 44% in neonatal mortality rate,
54% in IMR, 64% in under-five mortality rate, and 66% in
postnatal mortality rate) (35). Sastry reported significant
decrease in under-five mortality from 117 per 1,000 live
births in 1970 to less than 50 by 1991 in Brazil (72).
In some countries, however, sustainable health improve-
ments among children and young women were not
observed during the transition. Infant mortality among
Tsimane population in Bolivia did not decrease signifi-
cantly concomitantly with large reductions in adult
and old age mortality during 19502000 (105). Child
mortality in Nauru fluctuated and increased over time
from 6 to 10.8 per 1,000 population during 19602007
(131). Unlike other countries in South East Asia that
experienced a decline in infant mortality during 1960
1980, Thailand still struggled with high infant mortality
of 4045 per 1,000 live births in the 1980s (154). Kahn
et al. showed that children (04 years) and young adults
(2049 years) in rural South Africa experienced rapid
increases (two and five times, respectively) in mortality
rates over a 10-year period due to the HIV/AIDS epi-
demic (38, 40). In South Africa, the HIV/AIDS epidemic
led to the disease becoming the leading cause of death
among infants and young adults by 2000. Women suf-
fered more from HIV/AIDS and chronic diseases than
men (42).
What evidence is available to illustrate changing
patterns of causes of death?
In his second proposition, Omran postulated ‘During
the transition, a long-term shift occurs in mortality and
disease patterns’. Omran suggested a shift in the causes of
death from predominating infectious diseases to NCDs.
Therefore, we tried to identify how countries included in
this review stood in terms of ET stages over time and later
discuss specific transitions that did not follow the patterns
proposed by Omran.
Table 2 shows a summary of countries at various ET
stages over time. Industrialised countries generally started
ET earlier but proceeded slowly. Western European
countries such as Sweden, United Kingdom, and France
took most of the 19th century to shift from Stage 2 to Stage
3 and then a further half-century from Stage 3 to Stage 4
(108, 122, 124, 165). Cuba, USA, and Australia entered
Stage 2 later than many European countries (53, 54, 66, 67,
126) but reached Stage 3 almost at the same time. The
Netherlands (113) faced Stage 1, ‘the age of famine and
pestilence’, when USA and Australia were encountering
Stage 2. Hungary moved rapidly from Stage 2 to Stage 3 at
the end of the 20th century, after the rapid political
changes, and is now in Stage 4 of ET with declining
cardiovascular mortality and increasing life expectancy
(109). The same stage, with declining cardiovascular
mortality, was observed in Canada during 19781996
(51). In the former Soviet Union, ET did not progress
homogeneously across different geographical regions in
the country. The male population in the northern part
experienced higher mortality due to chronic diseases, such
as cardiovascular diseases, injuries, and lung cancer (166).
Spain entered Stage 1 at the beginning of the 19th
century (116, 117). The number of deaths have fluctuated
and have slightly increased since the beginning of the
19th century in Spain, with several severe mortality crises
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including the cholera epidemic in 1855, the influenza
pandemic in 1918, and the nutritional deficiency problem
during the Spanish Civil War in 1941. At the beginning of
the 20th century, circulatory mortality replaced infectious
diseases as the leading cause of death (114). By the end
of the century, circulatory disease was responsible for
75% of total deaths and less than 5% deaths were related
to infectious disease, a characteristic of Stage 3 (114).
Table 2. Timeline of selected countries reported to be at various stages of epidemiological transition
Stage 1 Stage 2 Stage 3 Stage 4
18701874 United Kingdom (153,
157), Sweden (153, 157),
Finland (153, 157), Iceland
(153, 157), USA (66),
Germany (167)
18751879 The Netherlands (113)
18801884
18851889
18901894
18951899
19001904 Spain (114, 116, 117)
19051909
19101914 United Kingdom (124, 153, 157),
Sweden (153, 157), Finland
(153, 157), Iceland (153, 157),
The Netherlands (113)
19151919
19201924 Mexico (17) Spain (114, 168)
19251929
19301934 Germany (167)
19351939 Japan (91)
19401944
19451949 Costa Rica (55)
19501954 Hong Kong (154),
Trinidad and Tobago
(64, 65)
Japan (91, 158), Ghana (32),
Canada (47, 169)
The Netherlands (113),
United Kingdom (124, 153, 157),
Sweden (153, 157), Iceland
(153, 157)
19551959 China (158)
19601964 Cuba (140), Puerto Rica (140)
19651969 Hong Kong (154), Singapore
(154)
Spain (114, 116, 117),
Costa Rica (55)
19701974 Peru (77) Trinidad and Tobago (64, 65) Japan (158), Mauritius (34),
Canada (169)
Netherland (113)
19751979 Korea (95)
19801984
19851989 Mexico (59, 140) Hong Kong (154) Malaysia (154) Costa Rica (55), Canada
(47), Spain (168)
19901994 Peru (77) Seychelles (37), Ghana (32),
Cuba (54)
Japan (158), France (108),
Australia (126, 127),
Trinidad and Tobago (65)
19951999 Mexico (17), Korea (93) China (158)
20002004 India (85, 86), Thailand
(100, 101)
Mexico (60), Peru (76),
Hungary (109), Brazil
(69, 73, 118)
20052009 Vietnam (104),
Mexico (170)
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The fourth stage, which is characterised by declining
circulatory disease, increasing degenerative diseases, such
as malignant neoplasms and metabolic disease, and a
stable, low proportion of infectious disease, was observed
in Spain at the beginning of the 21st century (119).
Up to the mid-20th century, average life expectancies
in LMICs were much lower than those of industrialised
countries, largely driven down by premature infectious
disease mortality. After World War II, most countries
progressed faster and followed a general trend of conver-
ging and increasing life expectancy. Most LMICs entered
Stage 2 later than high-income countries (in the second
half of the 20th century), but they subsequently moved
on to the next stages of ET more rapidly than that of
the high-income countries. This faster transition was
observed in Brazil (70, 74), Chile (75), China (79, 80,
155), Japan (91), Korea (93), Mexico (60), Peru (76, 77,
171), and Vietnam (104), perhaps because of greater
economic growth and improvements in health. By the end
of the 20th century, the proportion of ailments related to
circulatory disease had increased to 75% in Chile (75).
Diabetes mortality in Mexico increased slightly during
19802000 (62). By 2004, Mexico had progressed further
in the ET, with NCD and injury as a major burden of
disease [75% of all deaths in 2004 were due to NCDs,
mainly due to ischaemic heart diseases (13%), diabetes
mellitus (10%), cerebrovascular diseases (6%), liver cir-
rhosis (6%), and road traffic accidents (4%)] (60).
A variant of the non-Western transition model has
been formulated as the ‘protracted polarised transition
model’, in order to account for the process of epidemio-
logical polarisation. Frenk et al. conceptualised this
extended variant of the ET theory based on Latin
American data. Latin America had experienced a resur-
gence of malaria and dengue fever, along with a burden of
infectious diseases and NCDs across regions and social
classes, with widening health gaps across regions and
social classes due to an unequal distribution of health
interventions. The epidemiological polarisation element is
characterised by the overlap of eras, a persistence of
infectious diseases combined with the emergence of
NCDs and new epidemic diseases, capturing also in-
creased geographical and social health inequalities. They
also showed several main features of the protracted
polarised model; that the period of mortality decline is
short in contrast with the classical model; the onset of
mortality decline does not begin before the 20th century;
infectious diseases are not yet completely controlled, with
consequent overlaps of stages and unequal distributions
of wealth and health; and re-emergence of old diseases
that did not feature in the original ET theory (18).
Evidence from some countries confirmed the pro-
tracted epidemiological polarisation (32, 38). Agyei-
Mensah and de-Graft Aikins described how Ghana had to
deal simultaneously with persistent infectious diseases
predominantly among poor people, increasing NCDs
predominantly among wealthy people, and the emergence
of the HIV/AIDS epidemic (32). Kahn et al. (38) examined
trends in age-specific mortality in a rural South African
population and reported a ‘counter transition’ of increas-
ing mortality among children and young adults due
to acute diarrhoea and malnutrition, ‘epidemiological
polarisation’ from a greater mortality burden among
disadvantaged groups, and a ‘protracted transition’ with
a coexistence of HIV/AIDS and chronic NCDs in older
adults (38, 39, 41). Peru also faces a double burden of
persistent communicable diseases and NCDs, while deal-
ing with injuries, re-emerging infections (TB, malaria), and
HIV/AIDS. The country also suffers from inequalities in
health and wealth within the country. This situation
created an overlap of stages, broadening the gaps in health
status among social classes and geographical regions (76,
77, 171).
Determinants of ET
Omran postulated that ‘The shifts in health and disease
patterns that characterize the epidemiologic transition
are closely associated with the demographic and socio-
economic transition that constitute the modernization
complex’. Demographic and socio-economic determi-
nants, including sex, income level, education level, marital
status, ethnicity, regional differences, as well as wider
structural and environmental factors, can influence the
transition process and lead to unequal health outcomes.
In this review, we observed sex differentials in mortality
over time (46, 49, 51, 73, 80, 81, 86, 94, 106, 118, 123, 132,
157); regional disparities in mortality (57, 60, 62, 72, 74,
76, 77, 85, 102, 146, 148, 172); social, economic, and
mortality disparities across different ethnic groups (48, 49,
90, 98, 121, 125, 156); and climatic factors as determinants
of mortality transition (115, 124, 153).
Although demographic and socio-economic transitions
are significantly related to health improvement, some
health problems still exist in some countries because the
effects of socio-economic development and globalisation
can be detrimental. In China, the economic reform that
improved people’s living environment (i.e. income and
health care) had net effects on health. Conversely, eco-
nomic reform in Russia did not produce any tangible
economic and social benefits, and therefore health status
was stagnant or deteriorating. In Russia, morbidity and
mortality related to infectious disease increased after
the reform, which could be explained by a relaxed or
deteriorating public health network (152). Despite the
improvement of socio-economic status in Chile during
19702000, Chile still experienced a persistent burden of
tuberculosis, typhoid fever, and hepatitis, and at the
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same time, an increasing burden of HIV/AIDS (75). The
association between unintentional injuries and economic
development differed by age. In population groups aged
4574 years, unintentional injuries were negatively asso-
ciated with GNP per capita, reflecting lower rates of
injuries in countries with high GDP. Among the group
aged 75 years and above, the association was positive
with a higher rate of unintentional injuries in countries
with high GDP (137). The same pattern was observed for
intentional injuries such as suicide (150).
What deviations from the classic ET model have been
observed, and do these reveal emerging patterns?
The process of mortality transition can be complex
and dynamic, often influenced by demographic, socio-
economic, technological, cultural, environmental, and
biological drivers of change. We found numerous instances
of deviations from the classic ET theory when examin-
ing specific geopolitical areas. A general assumption that
current LMICs will experience the same transitional
patterns as those countries already industrialised, follow-
ing increased economic growth, is not proven. Some
countries have encountered serious obstacles preventing
them from completing certain stages of the transition,
often tied to their history, economic development, or
culture. Vallin and Mesle, referring to Eastern Europe
and Africa, challenged the theory and proposed the idea
that life expectancies are rapidly converging towards
a maximum level (173). Having achieved relatively high
life expectancies during the 1970s, a number of central
European and former Soviet republics experienced periods
of stagnation due to increasing cardiovascular mortality,
violence, and alcoholism, with declines in life expectancy
following the collapse of the USSR (97, 147, 174, 175).
The combination of a period of highly centralised com-
munist health planning, followed by a relatively disorderly
transition towards free-market economies, was not a
pattern that fitted into ET theory (175). In addition, the
global economic crisis has also played important roles in
this stagnation. Vallin and Mesle characterised the ‘cardi-
ovascular revolution’ as a specific stage of ET when life
expectancy increases and chronic diseases decline, which
some countries in Eastern Europe have not yet achieved.
Declining life expectancy in Eastern European countries is
also closely linked to unusual distortions in the structure
of age-specific mortality (173).
Many LMICs have started to close the gaps between
themselves and more advanced countries in terms of
economy, education, and health. While doing so, in the
late 20th century, new infectious diseases such as HIV/
AIDS and avian influenza showed remarkable abilities
to spread as global epidemics. Recent outbreaks of avian
influenza alerted the world to new susceptibilities to epi-
demics due to population growth, unplanned urbanisation,
anti-microbial resistance, poverty, and lifestyle changes in
communities. AIDS still persists as a major global health
concern although medical technology has progressed in
preventing new HIV infections and AIDS-related deaths.
A global summary of the AIDS epidemic in 2011 showed a
15% increase in the number of people living with HIV but a
13% decrease in the number of people newly infected with
HIV compared with 2001 (176). Although AIDS reporting
mostly focuses on national trends, there are often large
variations in HIV prevalence and epidemiological patterns
within countries. The epidemic of HIV/AIDS appears to
have stabilised in most countries, with sub-Saharan Africa
remaining the most heavily affected region, accounting for
71% of newly infected HIV cases in 2010. The AIDS
epidemic triggered a decrease, and in some cases a sharp
drop, in the life expectancy levels in many African
countries, which is bound to influence any interpretation
of their progress in ET terms. The major demographic
consequences of AIDS are something that Omran could
not have possibly anticipated in 1971 but represent a
salutary warning about the necessary complexity of any
comprehensive and generalisable understanding of ET.
The impact of wars and other forms of political violence,
frequent in Africa, and perhaps most extreme in Somalia
(177), introduces further uncertainty into understanding
ET. In other cases, impacts may not be sufficiently pop-
ulation-wide to hugely influence ET. For example, HIV/
AIDS in Thailand in the 1990s caused a 35% increase in
adult male mortality but did not have a huge impact on life
expectancy for the overall population in Thailand (101).
Declines in mortality in East Asian countries varied
over space and time due to different political systems,
different paces of economic growth, and geographical
differences. East Asia underwent a significant mortality
reduction in the second half of the 20th century. Japan
began this rapid progress (91) and was followed by Taiwan,
Hong Kong, Korea, and China (91, 158). Some African
countries have advanced at a much slower pace than
other countries with similar life expectancy levels. Many
African countries have not yet reached the third stage of
ET due to slow health care advances, and economic and
political crises. Downward trends in mortality have been
reversed in some areas as a consequence of the HIV/
AIDS pandemic. In sub-Saharan Africa as a whole, as
ET progresses problems tend to multiply, giving rise to
the concept of the quadruple burden of disease (existing
infectious diseases coupled with NCDs, injuries, and HIV/
AIDS), which combine to disadvantage poor and margin-
alised groups (31, 39, 40, 42, 145, 161). We mapped some
countries studied in this review to different sub-models
which account for differences in timing and pace of ET
in LMICs. The rapid sub-model related to countries
such as Hong Kong and China, which experienced rapid
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industrialisation but remain in the third stage of ET (152,
155, 178180). The intermediate sub-model refers to
middle- or low-income countries, such as India, Vietnam,
and Mexico, which still face overlapping infectious dis-
eases and NCDs (17, 58, 60, 62, 63, 104, 181). This suggests
that long-term shifts in patterns of mortality never entirely
displace infectious diseases by degenerative and man-
made disease and ageing, as Omran described in his theory.
The slow sub-model refers to countries that are least
prepared to handle the triple burden of disease, typically
in Africa (3841, 45).
We identified some new evidence of deviations from
ET theory. According to the original theory, infectious
diseases will gradually be eliminated as a major population
health threat. However, there are examples to the con-
trary. In Nauru, previously high mortality from infectious
diseases transitioned very rapidly into extremely high
mortality from diabetes, circulatory disorders, and acci-
dents over a short period, thus denying appreciable
increases in life expectancy (132). Meanwhile, Mexico
during 19221955 faced overlapping burdens of disease
and an increasing trend of NCDs among the younger age
groups, due to poverty and inability to afford healthcare
(17). High mortality burdens from external causes, such as
violence, in El Salvador did not follow cause of death
patterns elsewhere which were predominated by infectious
diseases at early stages of transition (182). Wolleswinkel-
van den Bosch et al. showed in a cluster analysis in
the Netherlands that the mortality decline in infectious
diseases and the rise in non-infectious diseases had
different time trends, in contrast with the classical inter-
pretation of the ET that assumes uniform changes (113).
Coste et al. evaluated the consistency of trends in causes of
deaths in France in the short term. They found that there
was a shift in mortality trends among adults during
19881999 that was marked by greater HIV infection,
injury, and poisoning compared to mortality trends during
19681979. Their findings showed patterns of causes
of deaths differing substantially from the classical patterns
of ET (108). Mortality trends in the Tsimane communities
in Bolivia showed decreased instances of deaths due
to infectious diseases but increased instances of accidents
and violence, particularly in the middle and late adult-
hood, which demonstrates a different pattern from the
classical ET theory (105).
Another study in Hungary during 19712007 showed
that the mortality patterns were different to what might
be expected in the fourth stage of ET, in that female death
rates increased due to ischaemic heart disease, while no
evidence of emergent or re-emergent diseases were found
and deaths related to external injuries declined (183). In
Canada, the shifting pattern of causes of death did not
entirely fit the theory. Lussier and Choiniere showed that
decline in mortality related to cardiovascular disease was
mostly concentrated in advanced ages, and the decline did
not occur at the same pace for men and women (47).
Fragmentation of the ET theory into distinctive stages
delimited in time has proven to be inappropriate for
Canada since the mid-20th century. The native Indian
population in Canada has been shown to follow a
different ET trajectory from the general population (52).
All these examples support existing criticisms that ET
theory fails to describe the transition in some countries
due to complexities of socio-economic, historical, poli-
tical, and cultural factors that caused deviations from
certain stages of the transition. Therefore, Omran’s ET
theory and its later developments cannot predict changes
in mortality and cause-of-death patterns across all coun-
tries and time periods, as noted previously in some earlier
reviews by Caselli et al. (10) and Gaylin and Kates (21).
Despite these findings, we can conclude that relatively
little research has concentrated on linking progress in ET
to the original theory. The interest in the socio-economic
determinants of ET has been greater than in the under-
lying disease shifts. Studies on mortality transitions in
various societies still use theoretical perspectives to
understand the process of population change by relating
mortality patterns to demographic and socio-economic
trends through the development of models (mechanisms
of interaction that describe the patterns, determinants,
and consequences of health and disease changes in diverse
populations).
Limitations of this study
One limitation of this paper is the potential of publication
bias. We are aware that many of the published papers are
papers that do not confirm to the ET theory, and hence
perhaps had higher chances of being accepted for pub-
lication as the utility of the theory was debated. Papers
with more ambiguous results may never be published. It
is a challenge to use mortality to compare ETs across
countries or regions, as many factors can influence the
mortality transition. The use of age-standardised death
rates might make the comparison across countries more
compelling, though the question on the comparability of
standard populations used remains valid.
Conclusions
Despite many criticisms of Omran’s theory, many re-
searchers are still using the ET theory as the framework for
their studies. In this review, we observe that the theory fits
the transition patterns in some countries but needs further
adjustments in other settings. With respect to broad
categories, the original ET theory can, to some extent,
continue to provide useful estimates of cause-specific
mortality changes in countries where the transition started
later than in industrialised countries and may contribute
usefully to predictions of cause-specific mortality.
There are numerous examples where deviations from
the classical ET theory have been observed in specific
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geopolitical settings since the theory was introduced four
decades ago. Although the current state of knowledge and
evidence on historical and contemporary cause-specific
mortality changes may still be too sparse to formulate
a new evidence-based theory that provides an integrated
formulation of the underlying processes of cause-specific
mortality change, the need to update the ET theory is
clear.
A comprehensive theory must start from the complex-
ity of reality, even though it may not always be possible
to measure all necessary parameters; a phenomenologi-
cal basis will not be adequate. A new evidence-based
formulation in terms of patterns of changes in causes of
death, and disruptions in health due to emerging risks, is
needed, which focuses on the underlying mechanisms and
cause-specific mortality changes that result, rather than
the current crude description of a decline in infectious
diseases and a rise in non-infectious diseases with little
reference to underlying determinants. Since comprehen-
sive data are not available on a 100% basis around the
world, judicious use will need to be made of the best
available sources of evidence, such as those coming,
for example, from the long-term surveillance of defined
populations by the INDEPTH Network in otherwise
uncounted regions (184). At the same time, optimal use
needs to be made of data archives which document ET
processes already experienced. The underlying processes
of mortality change need to be described more specifi-
cally with reference to causes of death, speed of mortality
changes, factors that cause disruption to health, and the
ways in which populations adapt to these disruptions.
Comparative analyses using standardised methods in
various population groups must provide information
for elaborating and refining models of transition, as is
needed to handle at least some of the many problems
associated with changes in population inequalities.
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